BioVie Inc. Other Interest and Dividend Income
BioVie Inc. (BIVI) reported Other Interest and Dividend Income of $51.40 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2019-09-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherInterestAndDividendIncome · last filed 2019-09-27
- BioVie Inc. other interest and dividend income for the quarter ending 2019-06-30 was $0.00.
- BioVie Inc. other interest and dividend income for the quarter ending 2019-03-31 was $0.00.
- BioVie Inc. other interest and dividend income for the quarter ending 2018-12-31 was $0.00.
- BioVie Inc. other interest and dividend income for the quarter ending 2018-09-30 was $51.40K.
- BioVie Inc. other interest and dividend income for fiscal 2019 was $51.40K.
- BioVie Inc. other interest and dividend income for fiscal 2017 was $222.93K.
| Period end | Other Interest and Dividend Income 3 month | Other Interest and Dividend Income 6 month | Other Interest and Dividend Income 9 month | Other Interest and Dividend Income 12 month |
|---|---|---|---|---|
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $0.00 derived: sum of 2 quarters · filed 2019-09-27 | $0.00 derived: sum of 3 quarters · filed 2019-09-27 | $51.40K 10-K · filed 2019-09-27 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | $0.00 derived: sum of 2 quarters · filed 2019-05-10 | $51.40K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-12 | $51.40K 10-Q · filed 2019-02-12 | ||
| 2018-09-30 | $51.40K 10-Q · filed 2018-11-14 | |||
| 2017-06-30 | $444.96K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $222.93K derived: sum of 2 quarters · filed 2018-10-05 | $222.93K 10-K · filed 2018-10-05 | |
| 2017-03-31 | -$222.03K 10-Q · filed 2017-05-09 | -$222.03K 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |